These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8895482)

  • 1. The peroxisome-proliferator ciprofibrate induces hypergastrinemia without raising gastric pH.
    Martinsen TC; Nesjan N; Rønning K; Sandvik AK; Waldum HL
    Carcinogenesis; 1996 Oct; 17(10):2153-5. PubMed ID: 8895482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiating hypergastrinemic effect by the peroxisome proliferator ciprofibrate and omeprazole in the rat.
    Hammer TA; Sandvik AK; Waldum HL
    Scand J Gastroenterol; 1998 Jun; 33(6):595-9. PubMed ID: 9669630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of the peroxisome proliferator ciprofibrate on the gastric mucosa and particularly the gastrin cell.
    Waldum HL; Kvetnoi IM; Sylte R; Schulze B; Martinsen TC; Sandvik AK
    J Mol Endocrinol; 1998 Feb; 20(1):111-7. PubMed ID: 9513087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antral G cells in rats during dosing with a PPAR alpha agonist: a morphometric and immunocytochemical study.
    Martinsen TC; Skogaker NE; Bendheim MØ; Waldum HL
    Med Electron Microsc; 2003 Mar; 36(1):18-32. PubMed ID: 12658348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Octreotide inhibits the enterochromaffin-like cell but not peroxisome proliferator-induced hypergastrinemia.
    Bakke I; Sandvik AK; Waldum HL
    J Mol Endocrinol; 2000 Aug; 25(1):109-19. PubMed ID: 10915223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPAR alpha stimulates the rat gastrin-producing cell.
    Bakke I; Hammer TA; Sandvik AK; Waldum HL
    Mol Cell Endocrinol; 2002 Sep; 195(1-2):89-97. PubMed ID: 12354675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciprofibrate stimulates the gastrin-producing cell by acting luminally on antral PPAR-alpha.
    Martinsen TC; Bakke I; Chen D; Sandvik AK; Zahlsen K; Aamo T; Waldum HL
    Am J Physiol Gastrointest Liver Physiol; 2005 Dec; 289(6):G1052-60. PubMed ID: 16099866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Species variation in gastric toxicity following chronic administration of ciprofibrate to rat, mouse, and marmoset.
    Eason CT; Spencer AJ; Pattison A; Howells DD; Henry DC; Bonner FW
    Toxicol Appl Pharmacol; 1988 Sep; 95(2):328-38. PubMed ID: 3138789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative hypolipidaemic and peroxisomal effects of ciprofibrate, clofibric acid, and their respective difluorocyclopropyl and 4-fluoro-substituted analogues in rat.
    Graham MJ; Winham MA; Old SL; Gray TJ
    Xenobiotica; 1996 Jul; 26(7):695-707. PubMed ID: 8819300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dexamethasone on ciprofibrate-induced cell proliferation and peroxisome proliferation.
    Rao MS; Subbarao V
    Fundam Appl Toxicol; 1997 Jan; 35(1):78-83. PubMed ID: 9024675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of gastric antisecretory effects of phenoxyisobutyrate derivatives in the rat and the mouse.
    Eason CT; Pattison A; Howells DD; Spencer AJ; Bonner FW
    Scand J Gastroenterol; 1988 Nov; 23(9):1063-71. PubMed ID: 3247588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of liver cell proliferation during ciprofibrate-induced hepatocarcinogenesis.
    Yeldandi AV; Milano M; Subbarao V; Reddy JK; Rao MS
    Cancer Lett; 1989 Sep; 47(1-2):21-7. PubMed ID: 2636030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cell proliferation and toxicity in Sprague-Dawley rats.
    Chen H; Huang CY; Wilson MW; Lay LT; Robertson LW; Chow CK; Glauert HP
    Carcinogenesis; 1994 Dec; 15(12):2847-50. PubMed ID: 8001245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of rat liver endoplasmic reticulum Ca(2+)-ATPase activity and mobilization of hepatic intracellular calcium by ciprofibrate, a peroxisome proliferator.
    Bennett AM; Williams GM
    Biochem Pharmacol; 1992 Feb; 43(3):595-605. PubMed ID: 1531754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irreversible inhibition of hepatic glutathione S-transferase by ciprofibrate, a peroxisome proliferator.
    Awasthi YC; Singh SV; Goel SK; Reddy JK
    Biochem Biophys Res Commun; 1984 Sep; 123(3):1012-8. PubMed ID: 6487318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium as a permissive factor but not an initiation factor in DNA synthesis induction in cultured rat hepatocytes by the peroxisome proliferator ciprofibrate.
    Bennett AM; Williams GM
    Biochem Pharmacol; 1993 Dec; 46(12):2219-27. PubMed ID: 8274155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of initiating activity of the peroxisome proliferator ciprofibrate in two-stage hepatocarcinogenesis.
    Glauert HP; Clark TD
    Cancer Lett; 1989 Feb; 44(2):95-100. PubMed ID: 2920376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cellular antioxidants and lipid peroxidation in rats.
    Glauert HP; Srinivasan S; Tatum VL; Chen LC; Saxon DM; Lay LT; Borges T; Baker M; Chen LH; Robertson LW
    Biochem Pharmacol; 1992 Mar; 43(6):1353-9. PubMed ID: 1562286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of pancreatic and testicular tumors in rats treated with ciprofibrate, a peroxisome proliferator.
    Rao MS; Subbarao V
    Cancer Lett; 1995 Nov; 97(2):185-8. PubMed ID: 7497461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the peroxisome proliferator ciprofibrate on hepatic cyclooxygenase and phospholipase A2 in rats.
    Leung LK; Glauert HP
    Toxicology; 1998 Feb; 126(1):65-73. PubMed ID: 9585093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.